乌罗立A通过调节AMPK/CREB/BDNF通路,表现出类似抗抑郁药的作用
Yaqian Di1,2, Rui Xue2, Xia Li2
1Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Ministry of Education, Beijing 100048, China.
Nutrients
|July 30, 2025
概括
乌罗立A (UA) 通过保护脑细胞和减少动物模型中的压力行为来表现出类似抗抑郁药的效果. 它的好处与激活AMPK/CREB/BDNF通路有关,这表明UA是抑郁症的潜在治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 乌罗立A (UA) 是埃拉基坦宁的代谢物,被认为具有潜在的大脑健康益处.
- 抑郁症是一种复杂的疾病,具有显著的未满足的治疗需求.
- 了解抑郁症的新治疗目标至关重要.
研究的目的:
- 为了研究乌罗立A (UA) 的类似抗抑郁药的特性.
- 在体外和体内探索UA作用的潜在分子机制.
- 评估UA在抑郁症细胞和动物模型中的疗效.
主要方法:
- 研究了UA对皮质激素诱导的PC12细胞损伤的影响.
- 评估了UA在小鼠尾部悬浮和强迫游泳试验中的类似抗抑郁药的活性.
- 利用慢性社会失败压力 (CSDS) 鼠标模型来评估行为和神经生物学变化.
主要成果:
- 治疗UA保护PC12细胞免受皮质激素诱导的损伤和炎症.
- 在行为测试中,UA显著降低了不动性,并在CSDS小鼠中缓解了类似抑郁和类似焦虑的行为.
- UA激活了AMPK/CREB/BDNF信号通路,这对其神经保护和行为效应至关重要.
结论:
- 乌罗立A具有显著的抗抑郁药类和焦虑缓解药类特性.
- AMPK激活是调解UA治疗效果的关键机制.
- 氨酸作为食补充剂或治疗抑郁症管理的治疗剂具有前景.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
358
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
358
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
580
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
580
G-protein Coupled Receptors
121.5K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.5K
Antidepressant Drugs: Overview
762
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
762
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K


